Prehospital Adenosine Diphosphate Receptor Blocker Use, Culprit Artery Flow, and Mortality in STEMI: The MADDEC Study

BACKGROUND AND OBJECTIVE: The newer adenosine diphosphate (ADP) receptor blockers ticagrelor and prasugrel are superior to clopidogrel in the long-term management of acute coronary syndrome (ACS). We evaluated the acute performance (prehospital loading) of these ADP receptor blockers in a primary pe...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Drug Investig
Auteurs principaux: Hautamäki, Markus, Lyytikäinen, Leo-Pekka, Eskola, Markku, Lehtimäki, Terho, Nikus, Kjell, Oksala, Niku, Tynkkynen, Juho, Hernesniemi, Jussi
Format: Artigo
Langue:Inglês
Publié: Springer International Publishing 2021
Sujets:
Original Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8245391/
https://ncbi.nlm.nih.gov/pubmed/34101137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-021-01045-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires